Currently, there is no way to correct inherited genetic mutations. However, research is ongoing in the field of gene therapy. For now, the focus is on managing cancer risk through surveillance, preventive measures, and targeted therapies. For example, individuals with BRCA mutations may benefit from PARP inhibitors, a class of drugs that target cancer cells with specific genetic abnormalities.
